Maulana, Basir W.
HRN: 25-23-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2024
CEFTAZIDIME 1GM (VIAL)
05/31/2024
06/07/2024
IVTT
1 Gram
Q8H
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes